As a global leader in peripheral intervention, Abbott offers a broad portfolio of innovative and minimally invasive products including guide wires, balloon dilatation catheters and stent systems for the treatment of peripheral artery disease (PAD), deep vein thrombosis and other venous diseases.
Peripheral vascular disease - caused by atherosclerosis, typically in the lower extremities - can result in claudication, which is a cramping pain in the leg when walking. More severe cases can result in pain at rest and, as ischemia worsens, ulceration. Blockages in renal arteries, iliac, femoral, and popliteal arteries may have debilitating effects on patients.
Placement of a metal stent in a stenotic or occluded blood vessel is intended to maintain patency and reestablish blood flow through the vessel by providing internal structural support. Given the broad range of challenges and the locations and types of blockages encountered, there is demand for a broad range of stent types and sizes paired with delivery and placement tools that may help to improve outcomes for our patients.
COMMITTED TO THE C.A.S.E.
At Abbott, we are committed to helping our customers by providing value across multiple touch points. We are committed to C.A.S.E.: Complex Cases, Awareness, Solutions, Education.
From Complex Endovascular Interventions to PAD Awareness, Custom Solutions and Education, we are committed to bringing customized programs for your health care system needs. We are Committed to the C.A.S.E.
ADVANCING THE TREATMENT OF PAD
Peripheral Artery Disease (PAD) is a serious disease that afflicts 8.5 million Americans.1 Yet 75% of adults have no awareness of PAD, with those at highest risk the least informed.2 Abbott is committed to fighting PAD and raising awareness—especially among underserved populations.
